Treatment of Akathisia by Propranolol

author

  • Shokrollah Abdollah-Zadeh Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:

A condition of motor restlessness ranging from a feeling of inner disquiet to inability to sit or lie quietly or to sleep.Called also acathisia, akithisia, and Kathisiophobia (1). The term ''Akathisia" was created by Haskovec in 1901. Haase first applied the term (1955) to the inability to sit still and to the other irri­tative hyperkinetic symptoms that are sometimes seen as a complication of pheno­thiazine or reserpine therapy. At present time this term refers almost exclu­sively to a side effect of neuroleptic drugs, often the symptom is of such inten­sity that it becomes impossible for the patients to sit still day or night and is described by them as more difficult to endure than any of symptoms for which they had been treated. Akathisia is overlooked frequently as a concomitant of early neuroleptic therapy. The frequence of neuroleptic induced akathisia ranges from 5% to 45%  (and in some reports 50%) 20% seems to be the most common estimate.Acquaintance with this symptom of akathisia which persists for a consider - able time after the drug has been withdrawn is important because it is some times mistaken for agitated depression and wrongly treated e.g. with electroconvulsive therapy (ECT) or with increasing phenothiazine drugs. The treatment of akathisia is difficult. Although anticholinergic drugs , amantadine and benzodiazepines are effective in some cases, they are most often  of limited benefit. Recently Beta-blockers were found to be effective in the treatment of neuro­leptic-induced akathisia proposed with a central Beta-blocker mechanism of action  (Lipophilic) with higher affinity for Beta l(Beta One) than Beta 2 adrenoceptors.  In the present study the author reviews the papers reported on this subject and evaluates the effects of aforementioned drugs with good result of lipophilic Beta-blocker drugs (propranolol) in the treatment of neuroleptic induced akathi­sia of Iranian patients in a psychiatric hospital. 

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Effect of Vitamin B6 versus Propranolol on Antipsychotic-Induced Akathisia: A pilot comparative double-blind study

Background: Akathisia is a common adverse effect of antipsychotic drugs and is characterized by subjective feelings of restlessness. First-line treatment usually consists of propranolol, a beta adrenergic antagonist. However, propranolol does not seem to be efficacious in up to 70% of patients. This study was aimed to evaluate the effect of vitamin B6 versus propranolol on antipsychotic-induced...

full text

Effect of Vitamin B6 versus Propranolol on Antipsychotic-Induced Akathisia: A pilot comparative double-blind study

Background: Akathisia is a common adverse effect of antipsychotic drugs and is characterized by subjective feelings of restlessness. First-line treatment usually consists of propranolol, a beta adrenergic antagonist. However, propranolol does not seem to be efficacious in up to 70% of patients. This study was aimed to evaluate the effect of vitamin B6 versus propranolol on antipsychotic-induced...

full text

Paraoxonase Inhibition by Propranolol

There are many evidences that human serum paraoxonase activity modifies plasma lipid profile and paraoxonase has an antiatherogenic property. Non-selective beta-blockers affect plasma lipid profile too, but they have atherogenic property when patients take these drugs in long term. In this study the effect of propranolol, a non-selective beta-blocker, on paraoxonase activity was investigated. L...

full text

Paraoxonase Inhibition by Propranolol

There are many evidences that human serum paraoxonase activity modifies plasma lipid profile and paraoxonase has an antiatherogenic property. Non-selective beta-blockers affect plasma lipid profile too, but they have atherogenic property when patients take these drugs in long term. In this study the effect of propranolol, a non-selective beta-blocker, on paraoxonase activity was investigated. L...

full text

A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol

Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...

full text

A 24-Week Treatment of Pediatric Hemangioma with Oral Propranolol

Background: Hemangioma is a benign vascular tumor that shouldbe treated in problematic situations.Propranolol efficacy, target dose, range of age, duration of treatment and complications arenot conclusive for treatment of pediatric hemangioma. Our goal was to study efficacy and safety of propranolol for hemangiomatreating in children. Methods: A randomized, open label crossover trial with two ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 12  issue 1

pages  63- 73

publication date 1988-03

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023